NUROKIND GOLD INJECTION 2 ML
By MANKIND PHARMA LIMITED
Contains: METHYLCOBALAMIN/CYNOCOBALAMINE/VITAMIN B...(See More)
About NUROKIND GOLD INJECTION 2 ML
- Multivitamin injectable called Nurokind Gold. Vitamin and nutritional deficits are treated and prevented with it. Additionally, it can be utilised to treat neurological issues and illnesses including anaemia. The active ingredients are nicotinamide/vitamin B3, pyridoxine/vitamin B6, and methylcobalamin/vitamin B12. A doctor or nurse will administer the Nurokind Gold injection to you in a clinic or hospital. Do not self-inject this medication. Before beginning this medication, let your doctor know whether you are pregnant, expecting a pregnancy, or nursing as well as all the medications and dietary supplements you use and any disorders or illnesses you have. Premature or freshly born newborns should not use this medication.
Benefits of NUROKIND GOLD INJECTION 2 ML
- For treatment and vitamin prevention, use Nurokind Gold injectable.
- Nutritional deficiencies are treated and prevented with the Nurokind Gold injection.
Frequently asked questions about NUROKIND GOLD INJECTION 2 ML
Mecobalamin, pyridoxine, and nicotinamide are all components of the Nurokind Gold injection. Mecobalamin is also known as vitamin B12, cyanocobalamin, and methylcobalamin.
Yes, one of the ingredients in Nurokind Gold injectable is vitamin B12/methylcobalamin.
Yes, one of the ingredients in Nurokind Gold injectable is vitamin B12/methylcobalamin.
Milind Patel
Reviewed on 10 Feb 2023
Milind Patel
Reviewed on 10 Feb 2023
Very cheap, helpful, friendly service
Dhaval Talaviya
Reviewed on 23 May 2023
Dhaval Talaviya
Reviewed on 23 May 2023
WHO GMP certified generic medicines at affordable prices are available
Ashutosh Buch
Reviewed on 24 Feb 2023
Ashutosh Buch
Reviewed on 24 Feb 2023
Nice experience, always!
shilpa purohit
Reviewed on 04 Sep 2023
shilpa purohit
Reviewed on 04 Sep 2023
Value for money I got a good discount on medicines
Dhara Patva
Reviewed on 10 Feb 2024
Dhara Patva
Reviewed on 10 Feb 2024
Good